January 23, 2026
Should PCOS Be Renamed? Patient Charity Verity Calls for Change
Verity, a patient charity, advocates for renaming Polycystic Ovary Syndrome to address its misleading name. The term inaccurately implies ovarian cysts, while PCOS is a hormonal and metabolic condition affecting over 10% of women. A survey of 5,000 patients and professionals highlights the need for a simpler name to improve diagnosis and treatment.
Key Takeaways
Why Polycystic Ovary Syndrome’s Name Is Misleading and Scary
The term ‘Polycystic Ovary Syndrome’ falsely suggests dangerous ovarian cysts, causing unnecessary anxiety. In reality, PCOS involves small follicular cysts that are not harmful but indicate hormonal imbalances affecting ovulation and metabolism.
PCOS Name Change Survey: Patient and Professional Feedback
Verity’s global consultation with 5,000 patients and experts found that 68% support a new name. Proposed alternatives focus on the condition’s hormonal nature (e.g., ‘Hormonal Metabolic Syndrome’) rather than ovarian structure.
Common Misconceptions About PCOS Cysts Debunked
The ‘polycystic’ label creates confusion, as the follicles in PCOS are not true cysts. They are immature eggs that fail to release during ovulation, not tumors or growths that rupture or cause pain.
Health Impacts of PCOS Beyond Ovaries
PCOS affects insulin resistance, weight management, and mental health (e.g., depression, anxiety). Addressing the condition as a systemic metabolic disorder could lead to earlier interventions beyond fertility-focused treatments.
Benefits of Renaming PCOS for Faster Diagnosis and Treatment
A revised name could reduce diagnostic delays (currently averaging 4 years) and improve patient understanding. 72% of survey participants reported feeling misunderstood due to the current terminology.
Source: Read full article